Synopsys [SNPS] vs Oracle [ORCL] Detailed Stock Comparison
Synopsys
NASDAQ
Loading...
Oracle
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Synopsys wins in 8 metrics, Oracle wins in 11 metrics, with 0 ties. Oracle appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Synopsys | Oracle | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 68.51 | 57.61 | Oracle |
| Price-to-Book Ratio | 9.27 | 34.39 | Synopsys |
| Debt-to-Equity Ratio | 108.34 | 519.59 | Synopsys |
| PEG Ratio | 39.85 | 35.00 | Oracle |
| EV/EBITDA | 60.08 | 34.08 | Oracle |
| Profit Margin (TTM) | 34.77% | 21.68% | Synopsys |
| Operating Margin (TTM) | 23.46% | 32.48% | Oracle |
| EBITDA Margin (TTM) | 23.46% | 32.48% | Oracle |
| Return on Equity | 15.55% | 82.38% | Oracle |
| Return on Assets (TTM) | 4.67% | 7.26% | Oracle |
| Free Cash Flow (TTM) | $1.28B | $-394.00M | Synopsys |
| Dividend Yield | N/A | 0.81% | N/A |
| 1-Year Return | 27.60% | 88.03% | Oracle |
| Price-to-Sales Ratio (TTM) | 17.63 | 12.26 | Oracle |
| Enterprise Value | $88.43B | $800.42B | Oracle |
| EV/Revenue Ratio | 14.21 | 13.95 | Oracle |
| Gross Profit Margin (TTM) | 80.16% | 70.19% | Synopsys |
| Revenue per Share (TTM) | $40 | $21 | Synopsys |
| Earnings per Share (Diluted) | $8.65 | $4.35 | Synopsys |
| Beta (Stock Volatility) | 1.12 | 1.39 | Synopsys |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Synopsys vs Oracle Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Synopsys | 1.50% | 5.03% | 25.88% | 40.60% | 22.61% | 33.68% |
| Oracle | 0.25% | 3.60% | 14.62% | 78.08% | 47.08% | 50.94% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Synopsys | 27.60% | 72.42% | 224.64% | 1,160.94% | 2,725.53% | 3,579.30% |
| Oracle | 88.03% | 223.98% | 353.74% | 533.47% | 927.89% | 1,787.05% |
Performance & Financial Health Analysis: Synopsys vs Oracle
| Metric | SNPS | ORCL |
|---|---|---|
| Market Information | ||
| Market Cap | $109.66B | $703.89B |
| Market Cap Category | Large cap | Mega cap |
| 10 Day Avg. Volume | 3,075,960 | 8,983,481 |
| 90 Day Avg. Volume | 2,001,640 | 13,543,030 |
| Last Close | $645.35 | $250.60 |
| 52 Week Range | $365.74 - $651.65 | $118.86 - $253.07 |
| % from 52W High | -0.97% | -0.98% |
| All-Time High | $651.72 (Jul 30, 2025) | $253.07 (Jul 29, 2025) |
| % from All-Time High | -0.98% | -0.98% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.10% | 0.11% |
| Quarterly Earnings Growth | 0.18% | 0.09% |
| Financial Health | ||
| Profit Margin (TTM) | 0.35% | 0.22% |
| Operating Margin (TTM) | 0.23% | 0.32% |
| Return on Equity (TTM) | 0.16% | 0.82% |
| Debt to Equity (MRQ) | 108.34 | 519.59 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $63.91 | $7.29 |
| Cash per Share (MRQ) | $91.93 | $3.99 |
| Operating Cash Flow (TTM) | $1.23B | $20.82B |
| Levered Free Cash Flow (TTM) | $1.94B | $678.00M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.81% |
| Last 12-Month Dividend | N/A | $1.70 |
Valuation & Enterprise Metrics Analysis: Synopsys vs Oracle
| Metric | SNPS | ORCL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 68.51 | 57.61 |
| Forward P/E | 39.85 | 35.00 |
| PEG Ratio | 39.85 | 35.00 |
| Price to Sales (TTM) | 17.63 | 12.26 |
| Price to Book (MRQ) | 9.27 | 34.39 |
| Market Capitalization | ||
| Market Capitalization | $109.66B | $703.89B |
| Enterprise Value | $88.43B | $800.42B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 14.21 | 13.95 |
| Enterprise to EBITDA | 60.08 | 34.08 |
| Risk & Other Metrics | ||
| Beta | 1.12 | 1.39 |
| Book Value per Share (MRQ) | $63.91 | $7.29 |
Financial Statements Comparison: Synopsys vs Oracle
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | SNPS | ORCL |
|---|---|---|
| Revenue/Sales | $1.60B | $15.90B |
| Cost of Goods Sold | $318.35M | $4.74B |
| Gross Profit | $1.29B | $11.16B |
| Research & Development | $553.98M | $2.65B |
| Operating Income (EBIT) | $376.43M | $5.19B |
| EBITDA | $490.66M | $7.00B |
| Pre-Tax Income | $396.19M | $4.15B |
| Income Tax | $47.18M | $725.00M |
| Net Income (Profit) | $345.11M | $3.43B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | SNPS | ORCL |
|---|---|---|
| Cash & Equivalents | $14.12B | $10.79B |
| Total Current Assets | $16.88B | $24.58B |
| Total Current Liabilities | $2.41B | $32.64B |
| Long-Term Debt | $10.62B | $96.83B |
| Total Shareholders Equity | $9.92B | $20.97B |
| Retained Earnings | $9.62B | $-15.48B |
| Property, Plant & Equipment | $1.16B | $0 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | SNPS | ORCL |
|---|---|---|
| Operating Cash Flow | $275.78M | $5.93B |
| Capital Expenditures | $18.69M | N/A |
| Free Cash Flow | $219.78M | $-2.92B |
| Debt Repayment | $0 | $-6.07B |
| Common Stock Repurchase | N/A | $-150.00M |
Short Interest & Institutional Ownership Analysis
| Metric | SNPS | ORCL |
|---|---|---|
| Shares Short | 6.54M | 20.68M |
| Short Ratio | 4.18 | 1.27 |
| Short % of Float | 0.04% | 0.01% |
| Average Daily Volume (10 Day) | 3,075,960 | 8,983,481 |
| Average Daily Volume (90 Day) | 2,001,640 | 13,543,030 |
| Shares Outstanding | 154.11M | 2.81B |
| Float Shares | 154.33M | 1.64B |
| % Held by Insiders | 0.00% | 0.42% |
| % Held by Institutions | 0.78% | 0.45% |
Dividend Analysis & Yield Comparison: Synopsys vs Oracle
| Metric | SNPS | ORCL |
|---|---|---|
| Last 12-Month Dividend | N/A | $1.70 |
| Last 12-Month Dividend Yield | N/A | 0.81% |
| 3-Year Avg Annual Dividend | N/A | $1.55 |
| 3-Year Avg Dividend Yield | N/A | 0.36% |
| 3-Year Total Dividends | N/A | $4.66 |
| Ex-Dividend Date | N/A | Apr 10, 2025 |